Cameroon HepB Birth Dose Feasibility Pilot
Improving Timeliness of Birth Dose Vaccines in 15 Health Facilities in Cameroon Through Integrating Immunizations Into Maternity and Newborn Care Services: A Feasibility Assessment
1 other identifier
interventional
13
1 country
13
Brief Summary
This feasibility assessment is to provide quantitative findings of an intervention integrating immunizations into maternity and newborn care across 15 health facilities in Cameroon.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2021
Shorter than P25 for not_applicable
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 17, 2021
CompletedFirst Posted
Study publicly available on registry
May 19, 2021
CompletedStudy Start
First participant enrolled
June 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 11, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedJuly 25, 2022
July 1, 2022
6 months
March 17, 2021
July 22, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Timeliness of birth dose vaccine administration
Median hours between birth and administration of oral polio and/or the BCG vaccine
20 weeks
Secondary Outcomes (1)
Coverage of birth dose vaccines
20 weeks
Study Arms (1)
Intervention Arm
EXPERIMENTALThese facilities will be those selected to have the intervention carried out.
Interventions
The purpose of the work is to integrate readily available birth dose vaccinations (Oral Polio and the Tuberculosis vaccine) currently given in a separate clinic into the maternity delivery services through improved training, checklist, and job aides.
Eligibility Criteria
You may qualify if:
- Facilities will be those that have both an immunization unit as well as a maternity ward
You may not qualify if:
- Facilities without both units
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Clinton Health Access Initiative Inc.lead
- Cameroon Expanded Program on Immunizationcollaborator
- Bill and Melinda Gates Foundationcollaborator
Study Sites (13)
CMA Dibi
Dibi, Adamaoua Region, Cameroon
CMA Mbe
Mbé, Adamawe, Cameroon
HD Biyem-Assi
Biyem Assi, Center, Cameroon
HD Cite Verte
Cite Verte, Center, Cameroon
CMMR Etoudi
Djoungolo, Center, Cameroon
CMA Ahala
Efoulan, Center, Cameroon
CSIU Mbalmayo II
Mbalmayo, Center, Cameroon
CSC Nkoabang
Mfou, Center, Cameroon
Hospital Nicolas Barre
Nkolndongo, Center, Cameroon
HD Obala
Obala, Center, Cameroon
CSC Baham
Baham, West Region, Cameroon
HD Foumbot
Foumbot, West Region, Cameroon
HD Mifi
Mifi, West Region, Cameroon
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ankouane Andoulo Firmin
Faculty of Medicine and Bio-Medical Sciences, University of Yaoundé
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 17, 2021
First Posted
May 19, 2021
Study Start
June 10, 2021
Primary Completion
December 11, 2021
Study Completion
December 31, 2021
Last Updated
July 25, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share
Data on individual participant data will not be shared with other researchers. All reports will have data aggregated to the facility level. No personal identifiers will be gathered.